Cellebrite DI (CLBT) Share-based Compensation (2020 - 2026)

Cellebrite DI has reported Share-based Compensation for 7 years, with the latest figure at $108.9 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 58.06% year-over-year to $108.9 million in Q2 2026; TTM through Jun 2026 was $108.9 million, a 58.06% increase from a year earlier, with the FY2025 full-year figure at $44.9 million, up 46.83% from the prior year.
• Share-based Compensation was $108.9 million for Q2 2026 at Cellebrite DI, up from $14.4 million in the prior quarter.
• The five-year high for Share-based Compensation was $108.9 million in Q2 2026, with the low at $2.9 million in Q1 2022.
• Average Share-based Compensation over 5 years is $21.3 million, with a median of $9.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation soared 1292.86% in 2022, then slipped 20.8% in 2023.
• Over 5 years, Share-based Compensation stood at $3.8 million in 2022, then surged by 33.61% to $5.1 million in 2023, then jumped by 83.18% to $9.3 million in 2024, then grew by 29.43% to $12.0 million in 2025, then soared by 807.54% to $108.9 million in 2026.
• The last three Share-based Compensation figures came in at $108.9 million (Q2 2026), $14.4 million (Q1 2026), and $12.0 million (Q4 2025), per Business Quant data.